Epilepsy: Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and children age 3 years and above. Safety and effectiveness for adjunctive therapy in pediatric patients below the age of 3 years have not been established.
Neuropathic Pain: Gabapentin is indicated for the treatment of neuropathic pain in adults age 18 years and above.
Safety and effectiveness in patients below the age 18 years have not been established.
Other Services
Country
Account